Finance

Beta
Lists
PCRX:NASDAQ
Pacira Biosciences Inc
$23.70
+1.17%
(+0.27) 1D
Jun 11, 1:30:51 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PCRX...
Open
$23.50
High
$24.03
Low
$23.34
Mkt. cap
928.61M
Avg. vol.
551.77K
Volume
97.61K
P/E ratio
189.67
52-wk high
$27.64
52-wk low
$18.80
EPS
$0.12
Beta
0.29
Shares outstanding
39.34M
No. of employees
827
Open
$23.50
High
$24.03
Low
$23.34
Mkt. cap
928.61M
Avg. vol.
551.77K
Volume
97.61K
P/E ratio
189.67
52-wk high
$27.64
52-wk low
$18.80
EPS
$0.12
Beta
0.29
Shares outstanding
39.34M
No. of employees
827
Analyst outlook
Analyst Ratings
Based on 6 analysts giving stock ratings to PCRX in the past 3 months
Buy
Buy
3
Hold
2
Sell
1
12 month forecast
Based on 6 Wall Street analysts offering 12 month price targets for PCRX in the last 3 months.
Highest
Current $23.70
$38.00 (+60.37%)
Average
$28.40 (+19.86%)
Lowest
$23.00 (-2.93%)
News stories
From sources across the web
About Pacira Biosciences Inc
CEO-
Employees827
Founded2006
HeadquartersBrisbane, California, United States
SectorPharmaceutical industry
Websitepacira.com
Last report
Apr 30, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.60 / $0.57
+5.05%beat
Revenue / Est. (USD)
177.38M / 173.45M
+2.26%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
181.10M
179.52M
196.87M
177.38M
Cost of goods sold
40.87M
34.28M
45.80M
36.41M
Cost of revenue
40.87M
34.28M
45.80M
36.41M
Research and development expenses
28.20M
25.97M
37.45M
28.07M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
88.58M
91.80M
101.61M
93.94M
Operating expense
131.10M
132.08M
153.38M
136.34M
Total operating expenses
171.97M
166.36M
199.18M
172.75M
Operating income
9.13M
13.15M
-2.31M
4.62M
Other non operating income
-10.74M
-110.00K
-134.00K
-135.00K
EBT including unusual items
-1.93M
9.52M
571.00K
5.00M
EBT excluding unusual items
-1.29M
17.30M
-4.04M
2.72M
Income tax expense
2.92M
4.09M
-1.07M
2.08M
Effective tax rate
-151.53%
42.97%
-186.69%
41.66%
Other operating expenses
-
-
-
-
Net income
-4.85M
5.43M
1.64M
2.92M
Net profit margin
-2.68%
3.03%
0.83%
1.64%
Earnings per share
0.74
0.70
0.57
0.60
Interest and investment income
5.01M
8.53M
2.30M
1.93M
Interest expense
-4.70M
-4.28M
-3.89M
-3.70M
Net interest expenses
313.00K
4.26M
-1.60M
-1.77M
Depreciation and amortization charges
-
-
-
-
EBITDA
36.46M
28.84M
24.53M
25.96M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer